癌细胞上的促红细胞生成素受体能否解释意外的临床发现？ - Suppr | 超能文献

Do erythropoietin receptors on cancer cells explain unexpected clinical findings?

作者信息

Clavo Bernardino

出版信息

J Clin Oncol. 2007 Apr 10;25(11):1447-8; author reply 1448. doi: 10.1200/JCO.2006.09.9713.

DOI:10.1200/JCO.2006.09.9713

Abstract

摘要

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

文档翻译

学术文献翻译模型，支持多种主流文档格式。

相似文献

1

Do erythropoietin receptors on cancer cells explain unexpected clinical findings?癌细胞上的促红细胞生成素受体能否解释意外的临床发现？

J Clin Oncol. 2007 Apr 10;25(11):1447-8; author reply 1448. doi: 10.1200/JCO.2006.09.9713.

2

Do erythropoietin receptors on cancer cells explain unexpected clinical findings?癌细胞上的促红细胞生成素受体能否解释意外的临床发现？

J Clin Oncol. 2006 Oct 10;24(29):4708-13. doi: 10.1200/JCO.2006.06.2737.

3

Heat shock protein 70, erythropoietin, and cancer.热休克蛋白70、促红细胞生成素与癌症

J Clin Oncol. 2007 Sep 20;25(27):4326; author reply 4326-7. doi: 10.1200/JCO.2007.13.0419.

4

Problems in identifying functional erythropoietin receptors in cancer tissue.在癌组织中识别功能性促红细胞生成素受体的问题。

J Clin Oncol. 2007 Apr 20;25(12):1627-8; author reply 1628. doi: 10.1200/JCO.2007.10.9728.

5

[The effect of the microenvironment of head and neck cancers on tumor progression].[头颈部癌症的微环境对肿瘤进展的影响]

Magy Onkol. 2009 Mar;53(1):51-9. doi: 10.1556/MOnkol.53.2009.1.8.

6

Understanding the presence and function of erythropoietin receptors on cancer cells.了解癌细胞上促红细胞生成素受体的存在及功能。

J Clin Oncol. 2006 Oct 10;24(29):4675-6. doi: 10.1200/JCO.2006.08.1190.

7

The impact of tumor expression of erythropoietin receptors and erythropoietin on clinical outcome of esophageal cancer patients treated with chemoradiation.促红细胞生成素受体和促红细胞生成素的肿瘤表达对接受放化疗的食管癌患者临床结局的影响。

Int J Radiat Oncol Biol Phys. 2008 May 1;71(1):152-9. doi: 10.1016/j.ijrobp.2007.09.027. Epub 2007 Oct 29.

8

Are erythropoietin receptors expressed in tumors? Facts and fiction--more careful studies are needed.肿瘤中是否表达促红细胞生成素受体？事实与假象——尚需更严谨的研究。

J Clin Oncol. 2007 May 1;25(13):1813-4; author reply 1815. doi: 10.1200/JCO.2006.09.7253.

9

Radiotherapy with or without erythropoietin for anemic patients with head and neck cancer: a randomized trial of the Radiation Therapy Oncology Group (RTOG 99-03).头颈部癌症贫血患者接受或不接受促红细胞生成素的放射治疗：放射治疗肿瘤学组的一项随机试验（RTOG 99-03）

Int J Radiat Oncol Biol Phys. 2007 Nov 15;69(4):1008-17. doi: 10.1016/j.ijrobp.2007.04.063. Epub 2007 Aug 23.

10

Erythropoietin and its receptor in breast cancer: putting together the pieces of the puzzle.促红细胞生成素及其受体在乳腺癌中的作用：拼凑谜题的各个部分

Oncologist. 2008 Jul;13(7):761-8. doi: 10.1634/theoncologist.2008-0110. Epub 2008 Jul 2.

引用本文的文献

1

Erythropoietin-stimulating agents and clinical outcomes in metastatic breast cancer patients with chemotherapy-induced anemia: a closed debate?促红细胞生成素刺激剂与化疗所致贫血的转移性乳腺癌患者的临床结局：一场无定论的争论？

Tumour Biol. 2014 Jun;35(6):5095-100. doi: 10.1007/s13277-014-1730-6. Epub 2014 Feb 20.